Skip to content
Clinical Trials – home
Medical University Of Vienna
Sponsor

Medical University Of Vienna

Austria Spitalgasse 23, Alsergrund, 1090 Vienna, Austria

About the sponsor

Research activity includes chronic kidney disease, end stage renal failure, hemodialysis, peritoneal dialysis, kidney transplantation, post-kidney transplantation, and late antibody mediated renal transplant rejection. The portfolio also extends to living donor kidney transplant care and regulatory T cell-based immune modulation in transplant settings.

  • Kidney failure
  • Renal transplant rejection
  • Dialysis-related care
  • Transplant immunology

Additional work covers immune-guided treatment strategies and post-transplant management in patients with complex renal disease.

About Specializations

Medical University Of Vienna runs clinical trials in conditions such as Chronic rhinosinusitis with nasal polyps, Major depression, Asthma, Prostate cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

63 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Venetoclax
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Saline
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:PEGVISOMANT
  • Sponsor:Medical University Of Vienna
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Escitalopram Oxalate
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Landiolol Hydrochloride
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Edoxaban
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Diphenhydramine Hydrochloride
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Medical University Of Vienna

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).